Physician profile
Daniel Navarro
NPI 1558434381
$1,762.11
in general payments reported to CMS, 2019-2025
13 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $99.08 · 2022: $36.37 · 2023: $609 · 2024: $331 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,195 · Entertainment: $64.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,195.04 |
| Entertainment | $64.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $318.73 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $291.66 | 2022-2025 | Infuse |
| Lkc Technologies, INC. | $185.41 | 2023-2024 | |
| Lumenis Be INC | $176.81 | 2023 | M22 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $175.88 | 2019 | |
| Sight Sciences, INC. | $145.14 | 2025 | Tearcare System |
| Optos, INC. | $106.14 | 2020-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Astrazeneca Pharmaceuticals Lp | $103.96 | 2023 | Farxiga |
| Maculogix, INC. | $81.99 | 2019 | |
| Lombart Brothers, INC. | $60.39 | 2025 | Opd-III |
| Menicon America INC | $57.00 | 2020 | |
| Alcon Vision LLC | $30.42 | 2024 | Precision 1 |
| Merge Healthcare Incorporated | $28.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Navarro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.